Discussing Your Feedback: Pain, Autism & hEDS Diagnostic Criteria | Office Hours (Ep 158)

In the season five finale of the Bendy Bodies Podcast, Dr. Linda Bluestein reflects on powerful listener feedback and opens up important conversations about language, intent, and identity in medicine. She clarifies the purpose behind episodes on pain neuroscience and mast cells in autism, acknowledges the concerns raised, and discusses the fine line between supporting physiology and honoring identity. She also addresses concerns raised about the neuroplasticity episode, reaffirming that the intent was never to minimize anyone’s pain or suggest a one‑size‑fits‑all approach. Instead, the goal was to share information that some may find empowering while honoring the reality and validity of every person’s experience. Dr. Bluestein also revisits the ongoing “Road to 2026” diagnostic criteria update for hEDS (hypermobile Ehlers-Danlos Syndrome), highlighting why labels matter for some patients and not for others. This wrap-up episode closes the season with transparency, humility, and a call for continued dialogue in the community.
In the season five finale of the Bendy Bodies Podcast, Dr. Linda Bluestein reflects on powerful listener feedback and opens up important conversations about language, intent, and identity in medicine. She clarifies the purpose behind episodes on pain neuroscience and mast cells in autism, acknowledges the concerns raised, and discusses the fine line between supporting physiology and honoring identity. She also addresses concerns raised about the neuroplasticity episode, reaffirming that the intent was never to minimize anyone’s pain or suggest a one‑size‑fits‑all approach. Instead, the goal was to share information that some may find empowering while honoring the reality and validity of every person’s experience. Dr. Bluestein also revisits the ongoing “Road to 2026” diagnostic criteria update for hEDS (hypermobile Ehlers-Danlos Syndrome), highlighting why labels matter for some patients and not for others. This wrap-up episode closes the season with transparency, humility, and a call for continued dialogue in the community.
Takeaways
-
Why pain is always real—even when labeled “non-structural”
-
How mast cell research intersects with autism without erasing identity
-
Why a hEDS diagnosis matters for some patients—but not for all
-
What the upcoming 2026 hEDS criteria changes could mean for the community
-
How listener feedback shapes the future of Bendy Bodies
Want more Dr. Linda Bluestein, MD?
Website: https://www.hypermobilitymd.com/.
YouTube: youtube.com/@bendybodiespodcast
Instagram: https://www.instagram.com/hypermobilitymd/
Facebook: https://www.facebook.com/BendyBodiesPodcast
X: https://twitter.com/BluesteinLinda
LinkedIn: https://www.linkedin.com/in/hypermobilitymd/
Newsletter: https://hypermobilitymd.substack.com/
Shop my Amazon store https://www.amazon.com/shop/hypermobilitymd
Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them.
Join YOUR Bendy Bodies community at https://www.bendybodiespodcast.com/.
YOUR bendy body is our highest priority!
Use this affiliate link for Algonot to get an extra 5% off your entire order: https://algonot.com/coupon/bendbod/
FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links
Learn more about Human Content at http://www.human-content.com
Podcast Advertising/Business Inquiries: sales@human-content.com
Part of the Human Content Podcast Network
Learn more about your ad choices. Visit megaphone.fm/adchoices
Transcripts are auto-generated and may contain errors
Dr. Linda Bluestein: [00:00:00] Welcome back to the most popular EDS podcast, bendy Bodies. I'm your host and founder, Dr. Linda Bluestein, the Hypermobility md. Please also check out my Substack newsletter, the Bendy Bulletin. You can subscribe@hypermobilitymd.substack.com. The team has been putting a lot of work into these newsletters, so be sure to check it out and let us know what you need.
We really wanna hear from you. Bendy Bodies is your community. We are here for you. Today we're doing another episode where you are my guest. We love it when you submit your questions directly on our website, bendy bodies podcast.com, where you can leave a voicemail or you can leave a written question While you're there, check out our new resources page where we have five resources, including red flags, to watch for, essential [00:01:00] guides, for joint hypermobility, and so much more.
Also check out our sponsors, including the Bendy Bodies boutique. We're launching new designs to have fun mixing and matching to create unique and fun merch. In this episode, I'm going to be covering some of the feedback that y'all shared on some prior episodes, and this also will be a wrap to season five.
We'll be back very shortly with season six, so don't go away. This is going to be really fun. So grab a salty snack, your favorite electrolyte drink. Get comfy in your favorite chair, and let's get ready to rock and roll.
So the first thing I would like to address is some feedback that I received from listeners about a conversation on No CPL Pain. When I recorded this conversation, my goal was to share information that might help people better understand a specific type of pain called noci Plastic pain. Pain is incredibly complex, and for those of us living with chronic or persistent pain, it can be exhausting and deeply personal.
I know that for many, it's not just a physical sensation, [00:02:00] but it's tied to years of being misunderstood, dismissed, or left without answers. And for some portions of this podcast today, I will be reading from my notes because I really wanna make sure to get this right. Some listeners expressed concern about this discussion and felt that it could be used to minimize or invalidate someone's pain, particularly by clinicians who might point to no CPL pain as a reason not to investigate structural or medical causes.
I want to be absolutely clear that was not the intent of the conversation and is not how I practice medicine. Pain is always very real and every person's pain story deserves to be heard and taken seriously. I also want to acknowledge that for some people, hearing about non-surgical or nervous system focused pain approaches can feel frustrating, especially if they've tried many of these strategies and are still suffering.
My intention was never to suggest that these ideas are a cure all, or that they work for everyone. Some problems require surgical or medical intervention, and there is no one size fits all solution [00:03:00] understanding, one possible contributor to pain. No CPL pain may help some people find tools that ease their symptoms.
Even if these tools don't work for you personally, they might offer insight into why your pain behaves the way it does, and perhaps open doors to other treatment options. If the episode stirred up strong emotions in you. I appreciate you sharing your concerns. It makes these conversations more nuanced and ultimately more helpful.
I would also like to address some of the feedback that I received about the episode 1 45 Are mast cells driving autism. This is really important to talk about because I know that there were some listeners who were upset By the way autism was discussed in this episode. Specifically, concerns were raised that the episode implied that autism should be cured, which is not how many in the autistic and neurodivergent communities view their identities.
I wanna take a moment to clarify my intent, acknowledge the impact, and engage in a thoughtful and respectful conversation. This is especially challenging because [00:04:00] as you probably know or would expect, there are thousands of people who listen to these podcast conversations. So while I do view it as a conversation, because I do take all of your feedback very seriously, I also want to share that it is really challenging recording these episodes because when I'm having a one-on-one conversation with someone, I know so many more details about their own personal situation.
Right now, there are thousands of people who are listening to this episode, and each person's situation is so unique. So I want you to understand that the goal of this particular episode about autism was not to promote the idea that autism itself should be eliminated or fixed. The idea was to explore whether mast cell dysfunction might play a role in certain physical or behavioral symptoms experienced by some individuals diagnosed with autism.
I respect and support the neurodiversity movement, and I'm neurodivergent myself. I have a DHD that was diagnosed in adulthood and something that I continue to struggle with. I [00:05:00] also recognize that autism is not inherently pathological. Many autistic individuals see their neurotype as a core part of who they are, not something to be treated or changed, and I honor that perspective.
Autism is a wide spectrum that includes a broad range of neurologic experiences and support needs. It's not a straight line from more to less autistic. It's more like a constellation of traits that show up differently in each person. This diversity makes it especially important not to generalize or assume that one size fits all.
So in this episode, we wanted to talk about supporting physiology, not erasing identity, exploring immune system dysfunction, sleep disruption, gastrointestinal issues or behavioral changes is about addressing underlying medical issues, not changing someone's identity. Seeking symptom relief does not mean trying to make someone less autistic.
The episode was intended for individuals or families who are actively seeking [00:06:00] solutions for specific medical or quality of life challenges. Everyone deserves access to care that makes them feel better if that's their personal goal, as we're gonna discuss in the next segment. Labels are very complex.
The autism diagnosis often includes people with very different biological underpinnings. Some people may have conditions like mast cell activation, mitochondrial dysfunction, or chronic infections that can contribute to their presentation and addressing these may help reduce suffering. Autism spectrum is still a commonly used and medically recognized term, but I understand that it's not perfect.
I will use it at times to reflect the diversity of experiences, not to rank or minimize them. I aim to use inclusive, respectful language, and always welcome feedback if I fall short. Even though the intention was to explore a medical hypothesis, I understand that the language or framing may have caused harm.
And for that, I'm truly sorry. I'm committed to listening and growing, and I appreciate those who took the time to share their concerns. I invite you to continue [00:07:00] the conversation. If you have thoughts, experiences, or perspectives that you want to share, I welcome them. This podcast is a space for evolving conversations and your voice matters here.
I do wanna remind you that as someone who has Hypermobile EDS myself, like many of you, I am very sensitive. So when you are sending in your comments, I really would urge you to focus them on solutions as much as you possibly can. I think that would be really, really helpful and so very much appreciated.
We're gonna take a quick break and when we come back we are gonna address some more feedback.
I am super excited to tell you about the Bendy Bodies boutique. I'm so proud of our fierce styles and flexible designs. These are created by hypermobile artists. For hypermobile shoppers. There are so many fun items from clothing, accessories, home goods, and my favorite are the bags. I especially love the weak, weaker tote with one of the EDS tough designs.
Whether you're shopping for yourself or someone you love, there's so many [00:08:00] options to choose from. A portion of the proceeds goes to support EDS nonprofit organizations. For more information, please visit bendy bodies boutique.com. Thank you so much for listening to Bendy Bodies. We really appreciate your support.
It really helps the podcast when you like, subscribe and comment on YouTube and follow rate and review on all audio platforms. This helps us reach so many more people and spread the information to everyone. Thank you so much again, and enjoy the rest of the episode.
Okay, we're back. And now I want to address some of your concerns that you had about the Road to 2026 episode and clarify my position about the importance of diagnosis. This is important to talk about because the diagnostic criteria for the most common type of EDS, hypermobile EDS, are being reviewed and updated with anticipated changes late 2025 or early 2026.
This process affects clinicians. Patients and researchers. So it's important [00:09:00] to discuss this early and often. Diagnosis matters for many reasons. A diagnosis can be essential for disability benefits, school or workplace accommodations, and insurance coverage for needed care. It can help people access specialists and guide more appropriate treatment plans.
It also provides validation and a name for what you've been living with that can help counter medical gaslighting. At the same time, not everyone needs or wants a label. Some patients focus more on symptom management than on a formal diagnosis. For others, pursuing a diagnosis can be emotionally draining, expensive, or even harmful if they encounter dismissive providers.
Please know that all of these perspectives are valid. My comments were never meant to downplay the value of a diagnosis. I recognize that the need for a label varies greatly based on personal circumstances, medical needs, and individual goals. With regards to the road to 2026 criteria, updates are a rare and significant opportunity to improve [00:10:00] recognition and care for things like symptomatic joint hypermobility and connective tissue disorders like EDS.
These processes, especially with clinical diagnoses, are very challenging and usually involve international experts, patient advocates, and researchers. Talking about this now helps prepare the community for changes and gives us a voice in the conversation. Thank you so much to all of you for your incredibly valuable feedback.
I started this podcast back in 2020 because I have hypermobile EDS and as a physician treating people with hypermobile EDS, I realized that there was such a huge knowledge gap between what was available to patients and the amount of knowledge that actually some clinicians had and some researchers had.
I wanted to try to make that information more accessible for people who are suffering from these conditions. At the same time, it's really challenging because no one has all the answers. So please understand that while I bring experts in from all across fields, [00:11:00] none of us has all the answers and we are all just trying to do our very best.
We are all still learning, and hopefully we will continue to get a lot more research in this area because there are so many people that are impacted by these conditions. I get messages from so many of you every single day, and it's so appreciated because you are the expert in your own body, and I really learn from my patients, my clients, and my listeners.
This is a wrap on season five, and I look forward to seeing you back in season six. Thank you for continuing to be here with me on this bendy body journey. I really want to thank you for listening to this week's episode of the Bendy Bodies. With the Hypermobility MD Podcast, you can help us spread the word about joint hypermobility and related disorders by leaving a review and sharing the podcast.
This helps raise awareness about these complex conditions. If you'd like to meet with me one-on-one, you can check out the available options on the services page of my website. At Hypermobility md.com. You can also find me, Dr. Linda Bluestein on Instagram, Facebook, [00:12:00] TikTok, Twitter, or LinkedIn At Hypermobility MD you can find human content, my producing team at Human Content Pods on TikTok and Instagram.
You can find full video episodes of every week on YouTube at Bendy Bodies Podcast. To learn about the Bendy Bodies program, disclaimer and ethics policy submission verification, and licensing terms and HIPAA release terms, or to reach out with any questions, please visit bendy bodies podcast.com. Bendy Bodies Podcast is a human content production.
Thank you for being a part of our community, and we'll catch you next time on the Bendy Bodies Podcast.
Thank you so much for watching. If you enjoyed this video, give it a thumbs up and leave a comment below. I love getting your feedback. Make sure to hit that subscribe button and ring the bell so you will never miss an update. We've got plenty more exciting content coming your way, and if you're looking for more episodes, just click on one of the videos on the screen right now.
Thanks again for tuning in and I'll see you in the next episode.